GM2-gangliosidosis, AB variant

Clinical, ophthalmological, MRI, and molecular findings

Deborah Renaud, Michael C Brodsky

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Citations (Scopus)

Abstract

GM2-gangliosidosis, AB variant is a very rare form of GM2 gangliosidosis due to a deficiency of GM2 activator protein, associated with autosomal recessive mutations in GM2A. Less than ten patients, confirmed by molecular analysis, have been described in the literature. A 12-month-old Hmong girl presented to the neurometabolic clinic for evaluation of global developmental delay, hypotonia, and cherry red spots. The parents were not known to be consanguineous. Her examination was remarkable for hypotonia with hyperreflexia and excessive startling. The head circumference was normal. An extensive neurometabolic evaluation was negative. Developmental regression began at 14 months of age. Retinal examination at 16 months of age disclosed 4+ cherry red/black spots with “heaped up” ring of whitish infiltrate surrounding both foveae but no evidence of optic atrophy or peripheral retinal abnormalities. Repeat magnetic resonance imaging (MRI) scan at 17 months of age revealed delayed but interval myelination associated with abnormal signal intensity of the bilateral thalami presenting as T2 hyperintensity of the posterior thalami in the region of the pulvinar nuclei and T2 hypointensity in the anterior thalami. Sequencing of the GM2A gene revealed a homozygous c.160 G>T mutation, predicted to result in a premature protein termination p. Glu54*.

Original languageEnglish (US)
Title of host publicationJIMD Reports
PublisherSpringer
Pages83-86
Number of pages4
DOIs
StatePublished - Jan 1 2016

Publication series

NameJIMD Reports
Volume25
ISSN (Print)2192-8304
ISSN (Electronic)2192-8312

Fingerprint

AB Variant Tay-Sachs Disease
G(M2) Activator Protein
Muscle Hypotonia
Magnetic resonance
Thalamus
Optics
GM2 Gangliosidosis
Genes
Magnetic Resonance Imaging
Pulvinar
Anterior Thalamic Nuclei
Imaging techniques
Optic Atrophy
Abnormal Reflexes
Mutation
Proteins
Parents
Head

Keywords

  • Abnormal signal intensity
  • Anterior thalamus
  • Global developmental delay
  • Repeat magnetic resonance imaging
  • Sandhoff disease

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)

Cite this

GM2-gangliosidosis, AB variant : Clinical, ophthalmological, MRI, and molecular findings. / Renaud, Deborah; Brodsky, Michael C.

JIMD Reports. Springer, 2016. p. 83-86 (JIMD Reports; Vol. 25).

Research output: Chapter in Book/Report/Conference proceedingChapter

Renaud, Deborah ; Brodsky, Michael C. / GM2-gangliosidosis, AB variant : Clinical, ophthalmological, MRI, and molecular findings. JIMD Reports. Springer, 2016. pp. 83-86 (JIMD Reports).
@inbook{9f95034bd67944a798ec5bd46d60dd7b,
title = "GM2-gangliosidosis, AB variant: Clinical, ophthalmological, MRI, and molecular findings",
abstract = "GM2-gangliosidosis, AB variant is a very rare form of GM2 gangliosidosis due to a deficiency of GM2 activator protein, associated with autosomal recessive mutations in GM2A. Less than ten patients, confirmed by molecular analysis, have been described in the literature. A 12-month-old Hmong girl presented to the neurometabolic clinic for evaluation of global developmental delay, hypotonia, and cherry red spots. The parents were not known to be consanguineous. Her examination was remarkable for hypotonia with hyperreflexia and excessive startling. The head circumference was normal. An extensive neurometabolic evaluation was negative. Developmental regression began at 14 months of age. Retinal examination at 16 months of age disclosed 4+ cherry red/black spots with “heaped up” ring of whitish infiltrate surrounding both foveae but no evidence of optic atrophy or peripheral retinal abnormalities. Repeat magnetic resonance imaging (MRI) scan at 17 months of age revealed delayed but interval myelination associated with abnormal signal intensity of the bilateral thalami presenting as T2 hyperintensity of the posterior thalami in the region of the pulvinar nuclei and T2 hypointensity in the anterior thalami. Sequencing of the GM2A gene revealed a homozygous c.160 G>T mutation, predicted to result in a premature protein termination p. Glu54*.",
keywords = "Abnormal signal intensity, Anterior thalamus, Global developmental delay, Repeat magnetic resonance imaging, Sandhoff disease",
author = "Deborah Renaud and Brodsky, {Michael C}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/8904_2015_469",
language = "English (US)",
series = "JIMD Reports",
publisher = "Springer",
pages = "83--86",
booktitle = "JIMD Reports",

}

TY - CHAP

T1 - GM2-gangliosidosis, AB variant

T2 - Clinical, ophthalmological, MRI, and molecular findings

AU - Renaud, Deborah

AU - Brodsky, Michael C

PY - 2016/1/1

Y1 - 2016/1/1

N2 - GM2-gangliosidosis, AB variant is a very rare form of GM2 gangliosidosis due to a deficiency of GM2 activator protein, associated with autosomal recessive mutations in GM2A. Less than ten patients, confirmed by molecular analysis, have been described in the literature. A 12-month-old Hmong girl presented to the neurometabolic clinic for evaluation of global developmental delay, hypotonia, and cherry red spots. The parents were not known to be consanguineous. Her examination was remarkable for hypotonia with hyperreflexia and excessive startling. The head circumference was normal. An extensive neurometabolic evaluation was negative. Developmental regression began at 14 months of age. Retinal examination at 16 months of age disclosed 4+ cherry red/black spots with “heaped up” ring of whitish infiltrate surrounding both foveae but no evidence of optic atrophy or peripheral retinal abnormalities. Repeat magnetic resonance imaging (MRI) scan at 17 months of age revealed delayed but interval myelination associated with abnormal signal intensity of the bilateral thalami presenting as T2 hyperintensity of the posterior thalami in the region of the pulvinar nuclei and T2 hypointensity in the anterior thalami. Sequencing of the GM2A gene revealed a homozygous c.160 G>T mutation, predicted to result in a premature protein termination p. Glu54*.

AB - GM2-gangliosidosis, AB variant is a very rare form of GM2 gangliosidosis due to a deficiency of GM2 activator protein, associated with autosomal recessive mutations in GM2A. Less than ten patients, confirmed by molecular analysis, have been described in the literature. A 12-month-old Hmong girl presented to the neurometabolic clinic for evaluation of global developmental delay, hypotonia, and cherry red spots. The parents were not known to be consanguineous. Her examination was remarkable for hypotonia with hyperreflexia and excessive startling. The head circumference was normal. An extensive neurometabolic evaluation was negative. Developmental regression began at 14 months of age. Retinal examination at 16 months of age disclosed 4+ cherry red/black spots with “heaped up” ring of whitish infiltrate surrounding both foveae but no evidence of optic atrophy or peripheral retinal abnormalities. Repeat magnetic resonance imaging (MRI) scan at 17 months of age revealed delayed but interval myelination associated with abnormal signal intensity of the bilateral thalami presenting as T2 hyperintensity of the posterior thalami in the region of the pulvinar nuclei and T2 hypointensity in the anterior thalami. Sequencing of the GM2A gene revealed a homozygous c.160 G>T mutation, predicted to result in a premature protein termination p. Glu54*.

KW - Abnormal signal intensity

KW - Anterior thalamus

KW - Global developmental delay

KW - Repeat magnetic resonance imaging

KW - Sandhoff disease

UR - http://www.scopus.com/inward/record.url?scp=85017192364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017192364&partnerID=8YFLogxK

U2 - 10.1007/8904_2015_469

DO - 10.1007/8904_2015_469

M3 - Chapter

T3 - JIMD Reports

SP - 83

EP - 86

BT - JIMD Reports

PB - Springer

ER -